These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 19664328)
1. [Research advancement on relationship between Epstein-Barr virus and breast cancer]. He JR; Song EW; Ren ZF Ai Zheng; 2009 Aug; 28(8):827-30. PubMed ID: 19664328 [TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus serology and gastric cancer incidence and survival. Koshiol J; Qiao YL; Mark SD; Dawsey SM; Abnet CC; Kamangar F; Lennette ET; Dong ZW; Taylor PR Br J Cancer; 2007 Dec; 97(11):1567-9. PubMed ID: 17987041 [TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus and breast cancer: serological study in a high-incidence area of nasopharyngeal carcinoma. He JR; Tang LY; Yu DD; Su FX; Song EW; Lin Y; Wang SM; Lai GC; Chen WQ; Ren ZF Cancer Lett; 2011 Oct; 309(2):128-36. PubMed ID: 21724319 [TBL] [Abstract][Full Text] [Related]
4. High incidence of elevated antibody titers to Epstein-Barr virus in patients with uveitis. Touge C; Agawa H; Sairenji T; Inoue Y Arch Virol; 2006 May; 151(5):895-903. PubMed ID: 16362642 [TBL] [Abstract][Full Text] [Related]
5. [Six anti-Epstein-Barr virus antibodies in healthy adults in a high risk area of nasopharyngeal carcinoma]. Yi B; Gu YL; Zong YS; Cheng WM; Ji MF Ai Zheng; 2009 Aug; 28(8):822-6. PubMed ID: 19664327 [TBL] [Abstract][Full Text] [Related]
6. EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma. Chan KH; Gu YL; Ng F; Ng PS; Seto WH; Sham JS; Chua D; Wei W; Chen YL; Luk W; Zong YS; Ng MH Int J Cancer; 2003 Jul; 105(5):706-9. PubMed ID: 12740922 [TBL] [Abstract][Full Text] [Related]
7. [Performance of the VIDAS automated immunoassay for the determination of Epstein-Barr virus serological status]. De Ory F; Guisasola ME; Sanz JC; García-Bermejo I Enferm Infecc Microbiol Clin; 2012 Dec; 30(10):618-20. PubMed ID: 22854635 [TBL] [Abstract][Full Text] [Related]
8. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription. Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040 [TBL] [Abstract][Full Text] [Related]
9. Localization of Epstein-Barr virus to infiltrating lymphocytes in breast carcinomas and not malignant cells. Khan G; Philip PS; Al Ashari M; Houcinat Y; Daoud S Exp Mol Pathol; 2011 Aug; 91(1):466-70. PubMed ID: 21600202 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis. Nystad TW; Myrmel H J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144 [TBL] [Abstract][Full Text] [Related]
11. Expression of EBV antibody EA-IgA, Rta-IgG and VCA-IgA and SA in serum and the implication of combined assay in nasopharyngeal carcinoma diagnosis. Xia C; Zhu K; Zheng G Int J Clin Exp Pathol; 2015; 8(12):16104-10. PubMed ID: 26884888 [TBL] [Abstract][Full Text] [Related]
12. Serum IgA antibodies to Epstein-Barr virus (EBV) early lytic antigens are present in primary EBV infection. Bhaduri-McIntosh S; Landry ML; Nikiforow S; Rotenberg M; El-Guindy A; Miller G J Infect Dis; 2007 Feb; 195(4):483-92. PubMed ID: 17230407 [TBL] [Abstract][Full Text] [Related]
14. Assessment of Epstein-Barr virus (EBV) serostatus by enzyme immunoassays: plausibility of the isolated EBNA-1 IgG positive serological profile. García T; Tormo N; Gimeno C; Navarro D J Infect; 2008 Oct; 57(4):351-3. PubMed ID: 18789535 [No Abstract] [Full Text] [Related]
15. Epstein-Barr virus and breast cancer: lack of evidence for an association in Iranian women. Kadivar M; Monabati A; Joulaee A; Hosseini N Pathol Oncol Res; 2011 Sep; 17(3):489-92. PubMed ID: 21207256 [TBL] [Abstract][Full Text] [Related]
16. Expression of VCA (viral capsid antigen) and EBNA1 (Epstein-Barr-virus-encoded nuclear antigen 1) genes of Epstein-Barr virus in Pichia pastoris and application of the products in a screening test for patients with nasopharyngeal carcinoma. Hu B; Hong G; Li Z; Xu J; Zhu Z; Li L Biotechnol Appl Biochem; 2007 May; 47(Pt 1):59-69. PubMed ID: 17129209 [TBL] [Abstract][Full Text] [Related]
17. Lytic viral replication as a contributor to the detection of Epstein-Barr virus in breast cancer. Huang J; Chen H; Hutt-Fletcher L; Ambinder RF; Hayward SD J Virol; 2003 Dec; 77(24):13267-74. PubMed ID: 14645583 [TBL] [Abstract][Full Text] [Related]
18. Investigation of Epstein-Barr virus in breast carcinomas in Tunisia. Hachana M; Amara K; Ziadi S; Romdhane E; Gacem RB; Trimeche M Pathol Res Pract; 2011 Nov; 207(11):695-700. PubMed ID: 22024152 [TBL] [Abstract][Full Text] [Related]
19. Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection. Robertson P; Beynon S; Whybin R; Brennan C; Vollmer-Conna U; Hickie I; Lloyd A J Med Virol; 2003 Aug; 70(4):617-23. PubMed ID: 12794726 [TBL] [Abstract][Full Text] [Related]
20. [Relationship between clinical stages of nasopharyngeal carcinoma and Epstein-Barr virus antibodies Rta/IgG, EBNA1/IgA, VCA/IgA and EA/IgA]. Cai YL; Zheng YM; Cheng JR; Wang W; Zhang YN; Wang WH; Wu YS; Zhong WM; Li J; Mo YK Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar; 30(3):509-11. PubMed ID: 20335122 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]